Genome-wide profiling of pluripotent cells reveals a unique molecular signature of human embryonic germ cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Pashai, Nikta ^a   Hao, Haiping ^b   All, Angelo ^a   Gupta, Siddharth ^a   Chaerkady, Raghothama ^a   de Los Angeles, Alejandro ^d,e,f   Gearhart, John D ^c   Kerr, Candace L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; AURKA GENE; CCNB1 GENE; CCNE1 GENE; CCNG1 GENE; CELL ADHESION; CELL CYCLE REGULATION; CELL METABOLISM; DMRT1 GENE; DNA REPAIR; DNA REPLICATION; EHD2 GENE; EMBRYO; EMBRYONIC GERM CELL; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GERM CELL; HBA1 GENE; HSPD1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IPO7 GENE; MAD2L1 GENE; MED7 GENE; MICROARRAY ANALYSIS; ONCOGENE K RAS; PARP1 GENE; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PRINCIPAL COMPONENT ANALYSIS; RBM26 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPANXA1 GENE; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CLUSTER ANALYSIS; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENOME; GENOME-WIDE ASSOCIATION STUDY; GERM CELLS; HUMANS; MICE; MICROSCOPY, PHASE-CONTRAST; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLURIPOTENT STEM CELLS; PRINCIPAL COMPONENT ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 84862642951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039088     Document Type: Article

References (112)

1. Dolci S, Pesce M, De Felici M, (1993) Combined action of stem cell factor, leukemia inhibitory factor, and cAMP on in vitro proliferation of mouse primordial germ cells. Mol Reprod Dev 35: 134-139.
2. Witschi E, (1948) Migration of the Germ Cells of Human Embryos from the Yolk Sac to the Primitive Gonadal Folds. Contributions in Embryology. Washington: Carnegie Institute pp. 67-80.
3. McKay DG, Hertig AT, Adams EC, Danziger S, (1953) Histochemical observations on the germ cells of human embryos. Anat Rec 117: 201-219.
4. Witschi E, (1963) Embryology of the Ovary. In: H.G.a.S. Grady DE, editors. pp. 1-10 editor. The Ovary. Baltimore: Williams and Wilkins.
5. Resnick JL, Bixler LS, Cheng L, Donovan PJ, (1992) Long-term proliferation of mouse primordial germ cells in culture. Nature 359: 550-551.
6. Matsui Y, Zsebo K, Hogan BL, (1992) Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70: 841-847.
7. Hiller M, Liu CF, Blumenthal PD, Gearhart J, Kerr C, (2011) Bone Morphogenetic Protein 4 Mediates Human Embryonic Germ Cell Derivation. Stem Cells Dev.
8. Kerr CL, Shamblott MJ, Gearhart JD, (2006) Pluripotent stem cells from germ cells. Methods Enzymol 419: 400-426.
9. Li XH, Cong HC, Wang Z, Wu CF, Cao YL, (2002) [Isolation and culture of human pluripotent embryonic germ cells]. Shi Yan Sheng Wu Xue Bao 35: 142-146.
10. Turnpenny L, Brickwood S, Spalluto CM, Piper K, Cameron IT, et al. (2003) Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells. Stem Cells 21: 598-609.
11. Park JH, Kim SJ, Lee JB, Song JM, Kim CG, et al. (2004) Establishment of a human embryonic germ cell line and comparison with mouse and human embryonic stem cells. Mol Cells 17: 309-315.
12. Andrews PW, (1998) Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. Apmis 106: 158-167; discussion 167-158.
13. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2007) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol.
14. Okita K, Ichisaka T, Yamanaka S, (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
15. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2007) Reprogramming of human somatic cells to pluripotency with defined factors. Nature.
16. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
17. Yamanaka S, (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460: 49-52.
18. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
19. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, et al. (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195.
20. Guo G, Yang J, Nichols J, Hall JS, Eyres I, et al. (2009) Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136: 1063-1069.
21. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, et al. (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448: 196-199.
22. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, et al. (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107: 9222-9227.
23. Leitch HG, Blair K, Mansfield W, Ayetey H, Humphreys P, et al. (2010) Embryonic germ cells from mice and rats exhibit properties consistent with a generic pluripotent ground state. Development 137: 2279-2287.
24. Kerr CL, Hill CM, Blumenthal PD, Gearhart JD, (2008) Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells 26: 412-421.
25. Zwaka TP, Thomson JA, (2005) A germ cell origin of embryonic stem cells? Development 132: 227-233.
26. Rossant J, (2007) Stem cells: the magic brew. Nature 448: 260-262.
27. Tanaka TS, Kunath T, Kimber WL, Jaradat SA, Stagg CA, et al. (2002) Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res 12: 1921-1928.
28. Saitou M, Barton SC, Surani MA, (2002) A molecular programme for the specification of germ cell fate in mice. Nature 418: 293-300.
29. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, et al. (2004) Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 427: 148-154.
30. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, et al. (2004) Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet 13: 727-739.
31. Sabour D, Arauzo-Bravo MJ, Hubner K, Ko K, Greber B, et al. (2011) Identification of genes specific to mouse primordial germ cells through dynamic global gene expression. Hum Mol Genet 20: 115-125.
32. Rao RR, Calhoun JD, Qin X, Rekaya R, Clark JK, et al. (2004) Comparative transcriptional profiling of two human embryonic stem cell lines. Biotechnol Bioeng 88: 273-286.
33. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RA, et al. (2004) Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet 13: 601-608.
34. Richards M, Tan SP, Tan JH, Chan WK, Bongso A, (2004) The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64.
35. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, et al. (2003) Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 260: 404-413.
36. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, et al. (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 100: 13350-13355.
37. Zeng X, Miura T, Luo Y, Bhattacharya B, Condie B, et al. (2004) Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22: 292-312.
38. Assou S, Lecarrour T, Tondeur S, Strom S, Gabelle A, et al. (2007) A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells.
39. Hanna LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA, (2002) Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev 16: 2650-2661.
40. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F, (2004) Oct-3/4 and Sox2 regulate Oct3/4 gene in ES cells. J Biol Chem.
41. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140.
42. Guy J, Ellis EA, Kelley K, Hope GM, (1989) Spectra of G ratio, myelin sheath thickness, and axon and fiber diameter in the guinea pig optic nerve. J Comp Neurol 287: 446-454.
43. Mise N, Fuchikami T, Sugimoto M, Kobayakawa S, Ike F, et al. (2008) Differences and similarities in the developmental status of embryo-derived stem cells and primordial germ cells revealed by global expression profiling. Genes Cells 13: 863-877.
44. Kerr CL, Hill CM, Blumenthal PD, Gearhart JD, (2008) Expression of pluripotent stem cell markers in the human fetal ovary. Hum Reprod 23: 589-599.
45. Perrett RM, Turnpenny L, Eckert JJ, O'Shea M, Sonne SB, et al. (2008) The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture. Biol Reprod 78: 852-858.
46. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, et al. (2008) Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253.
47. Choufani S, Shapiro JS, Susiarjo M, Butcher DT, Grafodatskaya D, et al. (2011) A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. Genome Res 21: 465-476.
48. Juric D, Sale S, Hromas RA, Yu R, Wang Y, et al. (2005) Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci U S A 102: 17763-17768.
49. Ruoslahti E, Jalanko H, Comings DE, Neville AM, Raghavan D, (1981) Fibronectin from human germ-cell tumors resembles amniotic fluid fibronectin. Int J Cancer 27: 763-767.
50. Malki S, Bibeau F, Notarnicola C, Roques S, Berta P, et al. (2007) Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells. Cancer Lett 255: 182-193.
51. Banito A, Gil J, (2010) Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep 11: 353-359.
52. Zhang L, Huang J, Yang N, Greshock J, Liang S, et al. (2007) Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res 13: 5314-5321.
53. Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, et al. (2007) Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Oncogene 26: 3511-3520.
54. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, et al. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 32: 594-605.
55. Narayan S, Jaiswal AS, (1997) Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine requires p53. J Biol Chem 272: 30619-30622.
56. Jaiswal AS, Narayan S, (2011) Assembly of the base excision repair complex on abasic DNA and role of adenomatous polyposis coli on its functional activity. Biochemistry 50: 1901-1909.
57. Jaiswal AS, Narayan S, (2008) A novel function of adenomatous polyposis coli (APC) in regulating DNA repair. Cancer Lett 271: 272-280.
58. Zalzman M, Falco G, Sharova LV, Nishiyama A, Thomas M, et al. (2010) Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464: 858-863.
59. Sorrentino E, Nazzicone V, Farini D, Campagnolo L, De Felici M, (2007) Comparative transcript profiles of cell cycle-related genes in mouse primordial germ cells, embryonic stem cells and embryonic germ cells. Gene Expression Patterns 7: 714-721.
60. Zhang Z, Jones A, Sun CW, Li C, Chang CW, et al. (2011) PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells 29: 229-240.
61. Shankar S, Nall D, Tang SN, Meeker D, Passarini J, et al. (2011) Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6: e16530.
62. Alagaratnam S, Lind GE, Kraggerud SM, Lothe RA, Skotheim RI, (2011) The testicular germ cell tumour transcriptome. Int J Androl 34: e133-150; discussion e150-131.
63. Viswanathan SR, Daley GQ, (2010) Lin28: A microRNA regulator with a macro role. Cell 140: 445-449.
64. Ramachandran R, Fausett BV, Goldman D, (2010) Ascl1a regulates Muller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway. Nat Cell Biol 12: 1101-1107.
65. Baharvand H, Fathi A, Gourabi H, Mollamohammadi S, Salekdeh GH, (2008) Identification of mouse embryonic stem cell-associated proteins. J Proteome Res 7: 412-423.
66. Van Hoof D, Mummery CL, Heck AJ, Krijgsveld J, (2006) Embryonic stem cell proteomics. Expert Rev Proteomics 3: 427-437.
67. Van Hoof D, Passier R, Ward-Van Oostwaard D, Pinkse MW, Heck AJ, et al. (2006) A quest for human and mouse embryonic stem cell-specific proteins. Mol Cell Proteomics 5: 1261-1273.
68. Kurisaki A, Hamazaki TS, Okabayashi K, Iida T, Nishine T, et al. (2005) Chromatin-related proteins in pluripotent mouse embryonic stem cells are downregulated after removal of leukemia inhibitory factor. Biochem Biophys Res Commun 335: 667-675.
69. Nagano K, Taoka M, Yamauchi Y, Itagaki C, Shinkawa T, et al. (2005) Large-scale identification of proteins expressed in mouse embryonic stem cells. Proteomics 5: 1346-1361.
70. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. (2007) Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625-635.
71. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
72. Zhu X, Liu B, Carlsten JO, Beve J, Nystrom T, et al. (2011) Mediator influences telomeric silencing and cellular life span. Mol Cell Biol 31: 2413-2421.
73. Gopalakrishnan S, Van Emburgh BO, Shan J, Su Z, Fields CR, et al. (2009) A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol Cancer Res 7: 1622-1634.
74. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, et al. (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27: 1033-1037.
75. Onyango P, Jiang S, Uejima H, Shamblott MJ, Gearhart JD, et al. (2002) Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages. Proc Natl Acad Sci U S A 99: 10599-10604.
76. Matson CK, Murphy MW, Griswold MD, Yoshida S, Bardwell VJ, et al. (2010) The mammalian doublesex homolog DMRT1 is a transcriptional gatekeeper that controls the mitosis versus meiosis decision in male germ cells. Dev Cell 19: 612-624.
77. Krentz AD, Murphy MW, Kim S, Cook MS, Capel B, et al. (2009) The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci U S A 106: 22323-22328.
78. Cai LY, Abe M, Izumi S, Imura M, Yasugi T, et al. (2007) Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers. Life Sci 80: 1458-1465.
79. Quinn MC, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN, (2009) Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer. Mol Carcinog 48: 648-661.
80. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, et al. (2004) Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112: 14-25.
81. Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, et al. (2006) Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103: 405-416.
82. He Z, Feng L, Zhang X, Geng Y, Parodi DA, et al. (2005) Expression of Col1a1, Col1a2 and procollagen I in germ cells of immature and adult mouse testis. Reproduction 130: 333-341.
83. Boiani M, Scholer HR, (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872-884.
84. Singh AM, Dalton S, (2009) The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5: 141-149.
85. Filipczyk AA, Laslett AL, Mummery C, Pera MF, (2007) Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res 1: 45-60.
86. Lee NS, Kim JS, Cho WJ, Lee MR, Steiner R, et al. (2008) miR-302b maintains "stemness" of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Biochem Biophys Res Commun 377: 434-440.
87. Zhang Z, Arora S, Zhou Y, Cherry A, Wang TS, (2011) Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization. Chromosoma 120: 73-82.
88. Wang L, Yin F, Du Y, Chen B, Liang S, et al. (2010) Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol 31: 225-232.
89. Guo Y, Zhang X, Yang M, Miao X, Shi Y, et al. (2010) Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer. J Med Genet 47: 616-622.
90. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R, (2011) Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19: 701-714.
91. Orford KW, Scadden DT, (2008) Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9: 115-128.
92. Corbet SW, Clarke AR, Gledhill S, Wyllie AH, (1999) P53-dependent and-independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene 18: 1537-1544.
93. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, et al. (1998) ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8: 145-155.
94. Van Sloun PP, Jansen JG, Weeda G, Mullenders LH, van Zeeland AA, et al. (1999) The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res 27: 3276-3282.
95. Roos WP, Christmann M, Fraser ST, Kaina B, (2007) Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair. Cell Death Differ 14: 1422-1432.
96. Filion TM, Qiao M, Ghule PN, Mandeville M, van Wijnen AJ, et al. (2009) Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol 220: 586-592.
97. Saretzki G, Armstrong L, Leake A, Lako M, von Zglinicki T, (2004) Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 22: 962-971.
98. Maynard S, Swistowska AM, Lee JW, Liu Y, Liu ST, et al. (2008) Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells 26: 2266-2274.
99. Tsunoda T, Takashima Y, Fujimoto T, Koyanagi M, Yoshida Y, et al. (2010) Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model. Neoplasia 12: 397-404.
100. Tichy ED, Pillai R, Deng L, Liang L, Tischfield J, et al. (2010) Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev 19: 1699-1711.
101. Mao Z, Bozzella M, Seluanov A, Gorbunova V, (2008) DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 7: 2902-2906.
102. McVey M, Lee SE, (2008) MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet 24: 529-538.
103. Menissier de Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. Embo J 22: 2255-2263.
104. Gao F, Kwon SW, Zhao Y, Jin Y, (2009) PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 284: 22263-22273.
105. Pardo M, Lang B, Yu L, Prosser H, Bradley A, et al. (2010) An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6: 382-395.
106. Kerr CL, Gearhart JD, Elliott AM, Donovan PJ, (2006) Embryonic germ cells: when germ cells become stem cells. Semin Reprod Med 24: 304-313.
107. Hiller M, Liu CF, Blumenthal PD, Gearhart J, Kerr C, (2010) Bone Morphogenetic Protein 4 Mediates Human Embryonic Germ Cell Derivation. Stem Cells Dev.
108. Chaerkady R, Kerr CL, Kandasamy K, Marimuthu A, Gearhart JD, et al. (2010) Comparative proteomics of human embryonic stem cells and embryonal carcinoma cells. Proteomics.
109. Prigione A, Hossini AM, Lichtner B, Serin A, Fauler B, et al. (2011) Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 6: e27352.
110. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
111. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
112. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.